Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.77 |
| ▸ | PKM | P14618 | 1/20 | 0.77 |
| ▸ | POLB | P06746 | 2/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.57 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.49 |
| ▸ | AADAT | Q8N5Z0 | 1/20 | 0.46 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.43 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.43 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.43 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.43 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.43 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.43 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.43 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.43 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL112098 | 1.00 | ALDH1A1 (0.77) | ALDH1A1PKMPOLBKMT2ACYP2D6 | |
| SCHEMBL592660 | 0.90 | POLB (0.64) | ALDH1A1PKMPOLBKMT2ACYP2D6 | |
| SCHEMBL2304471 | 0.87 | ALDH1A1 (1.00) | ALDH1A1PKMPOLBKMT2AMEN1 | |
| SCHEMBL1563867 | 0.87 | ALDH1A1 (1.00) | ALDH1A1PKMPOLBKMT2AMEN1 | |
| SCHEMBL2307309 | 0.86 | ALDH1A1 (0.74) | ALDH1A1PKMPOLBKMT2ACYP2D6 | |
| SCHEMBL7033312 | 0.83 | ALDH1A1 (0.74) | ALDH1A1PKMPOLBKMT2ACYP2D6 | |
| SCHEMBL6386661 | 0.82 | ALDH1A1 (0.90) | ALDH1A1PKMPOLBKMT2AMEN1 | |
| SCHEMBL11688646 | 0.82 | ALDH1A1 (0.52) | ALDH1A1PKMPOLBKMT2ACYP2D6 | |
| SCHEMBL3073609 | 0.81 | ALDH1A1 (0.51) | ALDH1A1PKMPOLBKMT2ACYP2D6 | |
| SCHEMBL11257389 | 0.81 | ALDH1A1 (0.62) | ALDH1A1PKMPOLBKMT2ACYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113144210-A | Antibacterial polypeptide compound and preparation method and application thereof | 梅奥(浙江)细胞工程有限责任公司 | 2021-07-23 | — | — | CN | claimed |
| EP-1284978-B2 | PROCESS FOR THE PURIFICATION OF A SALT OF CLAVULANIC ACID | SMITHKLINE BEECHAM PLC (GB) | 2008-09-10 | — | — | EP | claimed |
| US-7087748-B2 | Process | SMITHKLINE BEECHAM P.L.C. (GB) | 2006-08-08 | — | — | US | claimed |
| EP-1319086-B1 | PROCESS FOR THE PREPARATION OF CLAVULANIC ACID | SMITHKLINE BEECHAM PLC (GB) | 2004-11-03 | — | — | EP | claimed |
| EP-1284978-B1 | PROCESS FOR THE PURIFICATION OF A SALT OF CLAVULANIC ACID | SMITHKLINE BEECHAM PLC (GB) | 2004-08-18 | — | — | EP | claimed |
| US-20040063930-A1 | Selective adsorption | SMITHKLINE BEECHAM P.L.C. (GB) | 2004-04-01 | — | — | US | claimed |
| JP-2004509136-A | — | — | 2004-03-25 | — | — | JP | claimed |
| EP-1319086-A1 | PROCESS FOR THE PREPARATION OF CLAVULANIC ACID | SMITHKLINE BEECHAM PLC (GB) | 2003-06-18 | — | — | EP | claimed |
| WO-2002022846-A1 | PROCESS | SMITHKLINE BEECHAM P.L.C. (GB) | 2002-03-21 | — | — | WO | claimed |
| CN-118147247-A | Food flavoring compound succinyl amino acid and preparation method thereof | 华南理工大学 | 2024-06-07 | — | — | CN | disclosed |
| CN-113144210-A | Antibacterial polypeptide compound and preparation method and application thereof | 梅奥(浙江)细胞工程有限责任公司 | 2021-07-23 | — | — | CN | disclosed |
| US-7087748-B2 | Process | SMITHKLINE BEECHAM P.L.C. (GB) | 2006-08-08 | — | — | US | disclosed |
| US-6830863-B2 | Image-receiving sheet having image-receiving layer and four thermal transfer sheets each including a support, a light-to-heat converting layer and an image-forming layer, in which each of the sheets has a different color | FUJI PHOTO FILM CO., LTD. (JP) | 2004-12-14 | — | — | US | disclosed |
| EP-1319086-B1 | PROCESS FOR THE PREPARATION OF CLAVULANIC ACID | SMITHKLINE BEECHAM PLC (GB) | 2004-11-03 | — | — | EP | disclosed |
| WO-2002022846-A1 | PROCESS | SMITHKLINE BEECHAM P.L.C. (GB) | 2002-03-21 | — | — | WO | disclosed |
| WO-2001087891-A1 | PROCESS FOR THE PURIFICATION OF A SALT OF CLAVULANIC ACID | SMITHKLINE BEECHAM P.L.C. (GB) | 2001-11-22 | — | — | WO | disclosed |
| EP-0764167-A4 | BICYCLING LACTAM INHIBITOR OF INTERLEUKIN-1-BETA CONVERTING ENZYME | SANOFI WINTHROP INC (US) | 1997-09-17 | — | — | EP | disclosed |
| EP-0764167-A1 | BICYCLING LACTAM INHIBITOR OF INTERLEUKIN-1-BETA CONVERTING ENZYME | SANOFI WINTHROP, INC. (US) | 1997-03-26 | — | — | EP | disclosed |
| WO-1995033751-A1 | BICYCLING LACTAM INHIBITOR OF INTERLEUKIN-1-BETA CONVERTING ENZYME | SANOFI WINTHROP, INC. (US) | 1995-12-14 | — | — | WO | disclosed |
| US-4839068-A | OIL ADDITIVES FOR MINERAL OIL LUBRICANTS; FRICTION RESISTANCE' VISCOSITY IMPROVERS; FILM-FORMERS; INTERNAL COMBUSTION ENGINES | THE LUBRIZOL CORPORATION (US) | 1989-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040063930-A1 | Selective adsorption | GMPS, ITPA, TET2 | ALDH1A1 412/4885PKM 3573/4885POLB 530/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.